Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer

Experimental and Molecular Pathology

Volumn 96, Issue 1, 2014, Pages 48-53

  Šunderić, Miloš ^a   Dukanović, Blagoje ^b   Malenković, Vesna ^b   Nedić, Olgica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Clinical Medical Centre Be anijska Kosa   (Serbia)

Author keywords

2 macroglobulin; Colorectal cancer; IGFBP 2; Oxidation; Protein complexes; Sialylation

Indexed keywords

ALPHA 2 MACROGLOBULIN; SOMATOMEDIN BINDING PROTEIN 2;

ADULT; AGED; ARTICLE; CANCER CELL; CELL MEMBRANE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; OXIDATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIALYLATION;

COLORECTAL CANCER; IGFBP-2; OXIDATION; PROTEIN COMPLEXES; SIALYLATION; Α2 MACROGLOBULIN;

AGED; ALPHA-MACROGLOBULINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84889669154     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.11.006     Document Type: Article

References (39)

1. Abdul S., Abbass R. Determination the sialic acid in colorectal cancer and its correlation to some enzymes. Nat. J. Chem. 2009, 35:553-560.
2. Borth W., Scheer B., Urbansky A., Luger T.A., Sottrup-Jensen L. Binding of IL-1β to α-macroglobulins and release by thioredoxin. J. Immunol. 1990, 145:3747-3754.
3. Busund L.T., Richardsen E., Busund R., Ukkonen T., Bjørnsen T., Busch C., Stalsberg H. Significant expression of IGFBP2 in breast cancer compared with benign lesions. J. Clin. Pathol. 2005, 58:361-366.
4. Collett-Solberg P.F., Pinchas C. The role of the insulin-like growth factor binding proteins and IGFBP proteases in modulating IGF action. Endocrinol. Metab. Clin. N. Am. 1996, 25:591-609.
5. El Atiq F., Garrouste F., Remacle-Bonnet M., Sastre B., Pommier G. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int. J. Cancer 1994, 57:491-497.
6. Federici M., Porzio O., Zucaro L., Fusco A., Borboni P., Lauro D., Sesti G. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol. 1997, 129:121-126.
7. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.
8. Flyvbjerg A., Morgensen O., Morgensen B., Nielsen O.S. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J. Clin. Endocrinol. Metab. 1997, 82:2308-2313.
9. Fuller G.N., Hun Ree C., Hess K.R. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res. 1999, 59:4228-4232.
10. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell. Physiol. 2000, 183:1-9.
11. Hoeflich A., Reisinger R., Lahm H., Kiess W., Blum W.F., Kolb H.J., Weber M.M., Wolf E. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?. Cancer Res. 2001, 61:8601-8610.
12. Karasik A., Menczer J., Pariente C., Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J. Clin. Endocrinol. Metab. 1994, 78:271-276.
13. Kioi M., Yamamoto K., Higashi S., Koshikawa N., Fujita K., Miyazaki K. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 2003, 22:8662-8670.
14. Le Roith D. The insulin-like growth factor system. Exp. Diabesity Res. 2003, 4:205-212.
15. Levin R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
16. Liou J.M., Shun C.T., Liang J.T., Chiu H.M., Chen M.J., Chen C.C., Wang H.P., Wu M.S., Lin J.T. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. J. Clin. Endocrinol. Metab. 2010, 95:1717-1725.
17. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., Stampfer M.J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 1999, 91:620-625.
18. Michell N.P., Langman M.J., Eggo M.C. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Brit. J. Cancer 1997, 76(1):60-66.
19. Miyamoto S., Nakamura M., Yano K., Ishii G., Hasebe T., Endoh Y., Sangai T., Maeda H., Shi-chuang Z., Chiba T., Ochiai A. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. Cancer Sci. 2007, 98:685-691.
20. Mohnike K.L., Kluba U., Mittler U., Aumann V., Vorwerk P., Blum W.F. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins-2 and -3 in children with acute lymphoblastic leukaemia. Eur. J. Pediatr. 1996, 155:81-86.
21. 3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res. 2004, 64:977-984.
22. Qui Y., Patwa T.H., Xu Li, Shedden K., Misek D.E., Tuck M., Jin G., Ruffin M.T., Turgeon D.K., Synal S., Bresalier R., Marcon N., Brenner D.E., Lubman D.M. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J. Proteome Res. 2008, 7:1693-1703.
23. Rajaram S., Baylink D.J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 1997, 18:801-837.
24. Reuter S., Gupta S.C., Chaturvedi M.M., Aggrawal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic. Biol. Med. 2010, 49:1603-1616.
25. Robinson C.E., Keshavarzian A., Pasco D.S., Frommel T.O., Winship D.H., Holmes E.W. Determination of protein carbonyl groups by immunoblotting. Anal. Biochem. 1999, 266:48-57.
26. Ross R.J.M., Chew S.L., D'Souza Li., Yateman M., Rodriguez-Arnao J., Gimson A., Holly J., Camacho-Hubner C. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver. J. Endocrinol. 1996, 149:209-216.
27. Schüt B.S., Langkamp M., Rauschnabel U., Ranke M.B., Elmlinger M.W. Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J. Mol. Endocrinol. 2004, 32:859-868.
28. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 2000, 32:307-326.
29. So A., Levitt R.J., Eigl B., Fazil L., Muramaki M., Leung S., Cheang M.C., Nielsen T.O., Gleave M., Pollak M. Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer. Clin. Cancer Res. 2008, 14:6944-6954.
30. Song S.W., Fuller G.N., Khan A., Kong S., Shen W., Taylor E., Ramdas L., Lang F.F., Zhang W. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13970-13975.
31. Srichai M.B., Zent R. Integrin structure and function. Cell-Extracellular Matrix Interactions in Cancer 2010, 19-41. Springer, New York. R. Zent, A. Pozzi (Eds.).
32. Stadtman E.R., Levin R.L. Protein oxidation. Ann. N. Y. Acad. Sci. 2000, 899:191-208.
33. 2 macroglobulin in the circulation. Protein J. 2013, 32:138-142.
34. Takano K., Hall K., Fryklund L., Holmgren A., Sievertsson H., Uthne K. The binding of insulin and somatomedin A to human placental membrane. Acta Endocrinol.-Cop. 1975, 80:14-31.
35. Wang P.H. Altered glycosylation in cancer: sialic acids and sialyltransferases. J. Cancer Mol. 2005, 1:73-81.
36. Wang H., Wang H., Shen W., Huang H., Hu L., Ramdas L., Zhou Y.H., Liao W.S., Fuller G.N., Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003, 63:4315-4321.
37. 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis. J. Biol. Chem. 2001, 276:41668-41674.
38. WHO http://www.who.int/mediacentre/factsheets/fs297/en/.
39. Yeh C.C., Lai C.Y., Hsieh L.L., Tang R., Wu F.Y., Fung F.C. Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis 2010, 31:228-233.